Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teodora Radonic

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Journal for Immunotherapy of Cancer|February 1, 2024
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PETJohanna E E Pouw, Sayed M S Hashemi, Marc C Huisman, et al.
Plos One|April 6, 2012
Inflammation aggravates disease severity in Marfan syndrome patientsTeodora Radonic, Piet de Witte, Maarten Groenink, et al.
JAMA Oncology|November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLCMehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Outcomes of stereotactic ablative radiotherapy or surgery for early-stage lung cancer in patients with interstitial lung diseaseMathijs L Tomassen, Suzan F M Nijman, Esther J Nossent, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary HypertensionXue D Manz, Robert Szulcek, Xiaoke Pan, et al.
Archives of Pathology & Laboratory Medicine|July 8, 2017
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology SocietyErik Thunnissen, Timothy Craig Allen, Julien Adam, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancerTeodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung CancerTeodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
International Journal of Cardiology|September 25, 2012
MRI-assessed regional pulse wave velocity for predicting absence of regional aorta luminal growth in marfan syndromeEleanore S J Kröner, Arthur J H A Scholte, Patrick J H de Koning, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|February 1, 2024
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PETJohanna E E Pouw, Sayed M S Hashemi, Marc C Huisman, et al.
Plos One|April 6, 2012
Inflammation aggravates disease severity in Marfan syndrome patientsTeodora Radonic, Piet de Witte, Maarten Groenink, et al.
JAMA Oncology|November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLCMehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Outcomes of stereotactic ablative radiotherapy or surgery for early-stage lung cancer in patients with interstitial lung diseaseMathijs L Tomassen, Suzan F M Nijman, Esther J Nossent, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary HypertensionXue D Manz, Robert Szulcek, Xiaoke Pan, et al.
Archives of Pathology & Laboratory Medicine|July 8, 2017
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology SocietyErik Thunnissen, Timothy Craig Allen, Julien Adam, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancerTeodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung CancerTeodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
International Journal of Cardiology|September 25, 2012
MRI-assessed regional pulse wave velocity for predicting absence of regional aorta luminal growth in marfan syndromeEleanore S J Kröner, Arthur J H A Scholte, Patrick J H de Koning, et al.
Pageof 8